Kardigan’s tonlamarsen reduced a key biomarker for hypertension in a phase 2 trial, but missed the study’s other goal of significantly reducing blood pressure. The biotech evaluated monthly 90 mg ...

Physicists have directly tracked tiny points of darkness in laser light racing faster than light itself, without breaking ...

What's the impact on immune status, antioxidant capacity and acute phase proteins in 30 to 70 kg growing pigs?

A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.

If you’ve been struggling with unstable blood sugar, sudden energy crashes, or unexplained weight gain, Gluco6 might ...

New groundbreaking research by Stanford researchers has shown to do something that was previously believed not possible: ...

Efforts to reduce reliance on antibiotic growth promoters in modern pig farming are increasingly turning to plant-derived ...

A brief period of exercise may do more for your brain than you expect. New research led by the University of Iowa shows that ...

Monthly injections of tonlamarsen lowered AGT but didn’t reduce BP in patients already on multiple antihypertensive drugs.

Tonlamarsen “suppresses hepatic angiotensinogen production,” Laffin told the media ahead of the late-breaking session. “We know that AGT suppression reduces blood pressure among patients taking zero ...

New observations from the James Webb Space Telescope have identified the mechanism behind one of planetary science’s most ...

Strategic avoidance of uncertainty emerges under high cognitive demands, enabling faster decisions without impairing learning.